Wu, H.-C.; Hsieh, Y.-R.; Wang, W.; Chang, C.-W.; Chang, I.-W.; Chen, C.-L.; Chang, C.-C.; Chang, C.-H.; Kao, W.-Y.; Huang, S.-Y.
Potential Hepatic Lipid Markers Associated with Nonalcoholic Steatohepatitis and Fibrosis in Morbid Obesity Patients. J. Clin. Med. 2023, 12, 3730.
https://doi.org/10.3390/jcm12113730
AMA Style
Wu H-C, Hsieh Y-R, Wang W, Chang C-W, Chang I-W, Chen C-L, Chang C-C, Chang C-H, Kao W-Y, Huang S-Y.
Potential Hepatic Lipid Markers Associated with Nonalcoholic Steatohepatitis and Fibrosis in Morbid Obesity Patients. Journal of Clinical Medicine. 2023; 12(11):3730.
https://doi.org/10.3390/jcm12113730
Chicago/Turabian Style
Wu, Hua-Chien, Yin-Ru Hsieh, Weu Wang, Ching-Wen Chang, I-Wei Chang, Chi-Long Chen, Chun-Chao Chang, Chia-Hsuan Chang, Wei-Yu Kao, and Shih-Yi Huang.
2023. "Potential Hepatic Lipid Markers Associated with Nonalcoholic Steatohepatitis and Fibrosis in Morbid Obesity Patients" Journal of Clinical Medicine 12, no. 11: 3730.
https://doi.org/10.3390/jcm12113730
APA Style
Wu, H.-C., Hsieh, Y.-R., Wang, W., Chang, C.-W., Chang, I.-W., Chen, C.-L., Chang, C.-C., Chang, C.-H., Kao, W.-Y., & Huang, S.-Y.
(2023). Potential Hepatic Lipid Markers Associated with Nonalcoholic Steatohepatitis and Fibrosis in Morbid Obesity Patients. Journal of Clinical Medicine, 12(11), 3730.
https://doi.org/10.3390/jcm12113730
